Immune-Mediated Inflammatory Disease Forum
  • Publications Literature Highlights
  • Podcasts
  • Congresses
  • Educational Videos
  • Resources
  • Forum Live
  • Steering Committee
Sign in   Register FAQs Contact
Sign in  

Literature Highlights

Each month the Steering Committee selects the latest published original articles on immune-mediated inflammatory diseases, focusing on those with data on therapeutic interventions and those that have clinical impact.

↩ Back to Literature Highlights

PsA Literature Highlights - September 2024

Keywords:

  • Bimekizmab, Efficacy, IL-23, Long-term safety, Phase 3, Psoriasis, Psoriatic arthritis, Risankizumab, Upadacitinib
  • View Slides Download Slides
    Twitter
    E-Mail
    LinkedIn
    Literature review thumbnail: PsA Literature Highlights - September 2024

    Developed under the auspices of:

    University of Glasgow

    With sincere appreciation to the following supporters:

    Lilly logo Johnson & Johnson logo Abbvie logo UCB logo

    Follow us on:

    Twitter LinkedIn Facebook Apple Podcasts Apple Podcasts

    © 2014 - 2025 | Supported by CESAS Medical

    Steering Committee| Legal| Contact| Site Map
    APEX Award Winning logo
    Health Awards logo